profound, biotechnology applications in this large incumbent firm are more likely to be combined with other techno- logies than … in the new biotechnology firms (NBFs) which use biotechnology for both discovery and production of new therapeutic … more effective applications of the new technologies, but it could retard full adoption of biotechnology. It appears that …

The achievements in agricultural innovation over the past century have been impressive, supporting large increases in … operate as well as concentration in the agricultural biotechnology industry also emerged due to intellectual property rights …

protection. We use new survey data from India, the results of interviews with industry, government and multinational institutions …

. Using India as an example, it then brings together information gathered from both published sources and personal interviews …

tuberculosis drug samples that claim to be made in India and were sold in Africa, India, and five mid-income non-African countries … in India or non-African countries. Since this finding is robust for manufacturer-drug fixed effects, one likely …

and consequences of innovation, we have concentrated on the products we have rated as innovative. Section I explains our … sample. In Section II we discuss trends in the rate of drug innovation and the factors influencing those trends. Section III …

This paper studies how insurance coverage policies affect incentives for pharmaceutical innovation. In the United …

Innovation policy involves trading off monopoly output and pricing in the short run in exchange for incentives for …

pharmaceutical patent protection alone does not stimulate domestic innovation, as estimated by the US patent awards (both raw counts … innovation acceleration and technology transfer, conditional upon certain country variables. In particular, the interaction …Research on the effects of patent protection on innovation and technology transfer in the cross-country pharmaceutical …